How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/upper-respiratory-infection-due-to-neisseria-meningitidis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Upper Respiratory Infection due to Neisseria Meningitidis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Upper Respiratory Infection due to Neisseria Meningitidis (disease) competitive landscape: 2 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

2 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Upper Respiratory Infection due to Neisseria Meningitidis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	Line of therapy	First approval
Penicillin G Potassium In Plastic Container	Benzylpenicillin	Pfizer	Penicillin-class Antibacterial			1947-01-01
penicillin	penicillin	Karlstad University		Bacterial penicillin-binding protein, Beta-lactamase, Beta-lactamase TEM

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Karlstad University · 1 drug in Upper Respiratory Infection due to Neisseria Meningitidis
Pfizer · 1 drug in Upper Respiratory Infection due to Neisseria Meningitidis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Upper Respiratory Infection due to Neisseria Meningitidis:

Cite this brief

Drug Landscape (2026). Upper Respiratory Infection due to Neisseria Meningitidis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/upper-respiratory-infection-due-to-neisseria-meningitidis. Accessed 2026-06-10.

Upper Respiratory Infection due to Neisseria Meningitidis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing